Product Images Pirfenidone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Pirfenidone NDC 0781-2158 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structure - Pirfenidone 01
Figure 1 - Pirfenidone 02
This document appears to be displaying a chart that compares the effectiveness of Pirfenidone and Placebo in treating a medical condition related to pulmonary function. The chart measures the percentage of patients who experienced a decline or an increase in %FVC (Forced Vital Capacity) after a period of 52 weeks. The chart indicates that 25% of patients receiving Pirfenidone experienced a decrease in %FVC, while 20% experienced an increase. In contrast, among patients receiving Placebo, 45% experienced a decrease, while 0% experienced an increase. The bottom row of the chart shows the absolute change in %FVC from baseline to week 52 for both treatments.*
Figure 2 - Pirfenidone 03
Figure 3 - Pirfenidone 04
table.jpg - Pirfenidone 06
This is a dosing schedule for Pirfenidone Capsules 267mg. The table shows the recommended number of pills to take in the morning, afternoon, and evening during the first three weeks of treatment. During days 1-7, one pill should be taken during breakfast, lunch, and dinner for a total of three pills per day. During days 8-14, two pills should be taken during breakfast, lunch, and dinner for a total of six pills per day. From day 15 onwards, three pills should be taken during breakfast, lunch, and dinner for a total of nine pills per day.*
Label - image 01
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.